| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230577 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 9 Pages |
Abstract
Adjuvant concurrent chemoradiotherapy using three-dimensional conformal radiotherapy appears to improve locoregional control and survival in extrahepatic bile duct cancer patients with R1 resection. The postoperative carbohydrate antigen 19-9 level might be a useful prognostic marker to select patients for more intensified adjuvant therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jin-hong M.D., Eun Kyung M.D., Ph.D., Seung Do M.D., Ph.D., Sang-wook M.D., Ph.D., Si Yeol M.D., Ph.D., Sang Min M.D., Ph.D., Young Seok M.D., Yu Sun M.D., Sung-Gyu M.D., Ph.D., Shin M.D., Ph.D., Young-Joo M.D., Ph.D., Kwang-Min M.D., Ph.D.,